This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2022 Remove Law & Regulation Remove Safety Related Topics
Key account management Food and Drug Administration Sales FDA Patients Consulting Transportation Electronics Medicine Government More Related Topics >
article thumbnail

New quality requirements for tobacco products

European Pharmaceutical Review

JUNE 8, 2023

He is currently a CMC consultant with an interest in impurities and safety‑based limits. Assessment report Procedure under Article 5(3) of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products Procedure number: EMEA/H/A-5(3)/1490 EMA/369136/2020 Committee for Medicinal Products for Human Use (CHMP).

Food and Drug Administration 59
Food and Drug Administration FDA Manufacturing Law & Regulation 59
article thumbnail

How the Ukrainian clinical trial industry is overcoming disruption

Pharmaceutical Technology

SEPTEMBER 26, 2022

Clinical trials were thrown into turmoil on the morning of 24 February 2022, along with every aspect of life in Ukraine. Research recommencing has been accelerated by ingenuity from Ukrainian policymakers and businesses in two key areas: law and logistics. In July, approximately a third of companies had paused a trial in the country.

Transportation 52
Transportation Law & Regulation Key account management Management 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024